Plasma is an essential component of many treatments for several genetic, chronic and often rare medical conditions.
Plasma protein therapies are also needed to treat acute conditions like burns or shock. The proteins and clotting factors contained in plasma are used to create life saving medical therapies. The process of creating plasma protein therapies can from the point of collection to the time the patient receives the therapy can take anywhere from seven to nine months.
Plasma is also instrumental in the research and creation of numerous pharmaceuticals intended to stop or slow the progression of Alzheimer’s, a debilitating disease affecting over five million Americans.
The development of these treatments relies on a steady supply of donated plasma. Plasma cannot be created in a lab and must therefore be collected from healthy adults.
Just one person afflicted with the blood disorder Hemophilia A can use up to 1,237 donations of plasma in a single year of therapy!
Here are just a few of the many critical needs that blood plasma-derived products fulfill:
Critical Care Products: Used in critical care settings for treatment of shock, burns, and trauma.
Coagulation: Therapies used in treatment of bleeding disorders, including Hemophilia, Von Willebrand disease and Antithrombin III deficiency.
Immunoglobulins: To treat immunological disorders, such as chronic lymphocytic leukemia, congenital and acquired primary immune deficiency, as well as many other diseases that strike healthy people due to some change in the body’s defense system.
Wound Healing: Plasma products are often used during surgery and to facilitate the recovery from organ transplants and healing of wounds.
Respiratory: Used in the treatment of alpha1-antitrypsin deficiency (a genetic condition resulting in liver and lung failure)
Other therapies: Plasma is also used in the treatment of bone marrow transplants, pediatric HIV, hepatitis A and B, rabies, tetanus, and several other diseases or illnesses